A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoidsFrontiers in Bioengineering and BiotechnologyIF4.82026-01-210OAAI
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorderJOURNAL OF NEURODEVELOPMENTAL DISORDERSIF42024-11-260OAAI
Autistic-relevant behavioral phenotypes of a mouse model of cyclin-dependent kinase-like 5 deficiency disorderAUTISM RESEARCHIF5.62024-09-050OAAI
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorderNEUROBIOLOGY OF DISEASEIF5.62023-06-014OAAI
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency DisorderNEUROTHERAPEUTICSIF6.92022-10-016OAAI
Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorderCNS NEUROSCIENCE & THERAPEUTICSIF52022-08-064OAAI
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorderJOURNAL OF NEUROINFLAMMATIONIF10.12021-07-0826OAAI